Dopaminergic News and Research

RSS

Lipid Accumulation Linked to Senescence in Dopaminergic Neurons

A new research perspective was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 14 on July 19, 2024, entitled, "Lipid accumulation drives cellular senescence in dopaminergic neurons."

14 Aug 2024

Deep-Learning Model Identifies Parkinson's Disease-Specific Neuroanatomical Features

A deep-learning-based contrastive approach to examine magnetic resonance imaging (MRI) scans from Parkinson’s disease patients.

14 Aug 2024

The Importance of Antioxidant Therapy in Preventing Parkinson's Disease

The neurodegenerative condition known as Parkinson's disease is caused by the death of neurons that generate dopamine, a neurotransmitter essential for both motor control and cognitive function.

6 Aug 2024

C. elegans Study Reveals Impact of Embryonal Amphetamine Exposure

Amphetamine is a psychostimulant that has been used to treat a variety of brain dysfunctions. However, it is a highly abused drug.

31 May 2024

Genetically Engineered Stem Cells May Revolutionize Parkinson's Disease Treatment

The future treatment of Parkinson’s Disease has undergone tremendous development in recent years. Now, a breakthrough in research has emerged, delivering the strongest results for both side-effect-free and long-lasting treatment effects.

7 Dec 2023

Novel Gene Therapy Targets Core Motor Symptoms of Parkinson’s Disease

A team of researchers from the Shenzhen Institute of Advanced Technology (SIAT) at the Chinese Academy of Sciences (CAS) and their collaborators have devised a gene therapy approach aimed at selectively manipulating the affected circuitry in Parkinson’s disease.

6 Nov 2023

The proper implementation of stem cell-based disease models

Scientists have learned how to manufacture induced pluripotent stem cells (iPSC) from regular cells through genetic reprogramming during the last ten years.

29 Mar 2023

Foods with a high fat and sugar content change our brain, shows study

Chocolate bars, crisps and fries - why can't we just ignore them in the supermarket? Researchers at the Max Planck Institute for Metabolism Research in Cologne, in collaboration with Yale University, have now shown that foods with a high fat and sugar content change our brain: If we regularly eat even small amounts of them, the brain learns to consume precisely these foods in the future.

23 Mar 2023

Study provides new insight into the brain circuits involved in opioid addiction

The ongoing opioid epidemic continues to take a heavy toll on American communities, with more than 80,000 opioid-related deaths reported in 2021, according to the National Institutes of Health.

23 Feb 2023

Genetic variants that increase the risk of ADHD identified

Why are some people diagnosed with ADHD while others are not? And when is the seed of ADHD sown, in life or the womb?

10 Feb 2023

Researchers reveal novel mechanism that links interferon activation and α-synuclein function in neurons

There are no disease-modifying therapies for Parkinson’s disease that can alter the course of the disease.

25 Jul 2022

16 distinct cell populations identified in a key brain region for substance use disorders

In a work of systematic biology that advances the field, University of Alabama at Birmingham researchers have identified 16 distinct cell populations in a complex area of the midbrain called the ventral tegmental area, or VTA.

18 Apr 2022

Scientists recognize neuronal processes that regulate food cravings during pregnancy

Many people have experienced the sudden and unmanageable desire to eat a particular food. These desires, known as cravings, are very usual, especially during pregnancy.

From University of Barcelona 7 Apr 2022

Biologists show how genes may inhibit the growth of Parkinson’s disease in flies and mice

Parkinson’s disease is a neurodegenerative disease in which a specific type of neuron, the dopaminergic neuron, is destroyed.

21 Mar 2022

Research reveals involvement of secretory granules in Parkinson’s disease

Recent research states that the number of secretory granules (SGs) in tyrosine hydroxylase-positive neurons and the marker proteins secretogranin III substantially lowered in the substantia nigra and striatum regions of mice exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine.

13 Oct 2021

Dopaminergic News and Research

Lipid Accumulation Linked to Senescence in Dopaminergic Neurons

Deep-Learning Model Identifies Parkinson's Disease-Specific Neuroanatomical Features

The Importance of Antioxidant Therapy in Preventing Parkinson's Disease

C. elegans Study Reveals Impact of Embryonal Amphetamine Exposure

Genetically Engineered Stem Cells May Revolutionize Parkinson's Disease Treatment

Novel Gene Therapy Targets Core Motor Symptoms of Parkinson’s Disease

The proper implementation of stem cell-based disease models

Foods with a high fat and sugar content change our brain, shows study

Study provides new insight into the brain circuits involved in opioid addiction

Genetic variants that increase the risk of ADHD identified

Researchers reveal novel mechanism that links interferon activation and α-synuclein function in neurons

16 distinct cell populations identified in a key brain region for substance use disorders

Scientists recognize neuronal processes that regulate food cravings during pregnancy

Biologists show how genes may inhibit the growth of Parkinson’s disease in flies and mice

Research reveals involvement of secretory granules in Parkinson’s disease

Gene therapy may be safe and effective in treating AADC deficiency

Study discloses neuroprotective properties of aromatic turmerone and its derivatives

Experimental antibody therapies for neurodegenerative diseases may lead to brain inflammation

Scientists identify mystery protein that explains the origins of Parkinson's Disease

Study highlights the role of brain astrocyte cells in Parkinson's disease pathology

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics